CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Open-market buy See Explanation of Responses bought 170,000 shares at $5.25 ($892,500)
- 4 Open-market buy See Explanation of Responses bought 30,000 shares at $5.25 ($157,500)
- 4 Option exercise President & CEO acquired 1,000 shares (option exercise)
- 4 Open-market buy Director bought 2,000 shares at an average $5.43 ($10,861)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 4,000 shares at $5.19 ($20,760)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Open-market buy Director bought 3,000 shares at $7.14 ($21,431)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
Page 5 of 13 · 256 filings